574
Participants
Start Date
September 30, 2010
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
Linagliptin
Linagliptin once daily
Linagliptin
Linagliptin once daily
Metformin
Metformin twice or three time per day
Metformin
Metformin twice or three time per day
Linagliptin
Linagliptin once daily
Linagliptin
Linagliptin once daily
Linagliptin
Linagliptin once daily
1218.78.008 Boehringer Ingelheim Investigational Site, Akishima, Tokyo
1218.78.030 Boehringer Ingelheim Investigational Site, Amagasaki, Hyogo
1218.78.017 Boehringer Ingelheim Investigational Site, Annaka, Gunma
1218.78.006 Boehringer Ingelheim Investigational Site, Aomori, Aomori
1218.78.007 Boehringer Ingelheim Investigational Site, Aomori, Aomori
1218.78.009 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo
1218.78.013 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo
1218.78.032 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka
1218.78.040 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka
1218.78.037 Boehringer Ingelheim Investigational Site, Higashi Osaka, Osaka
1218.78.043 Boehringer Ingelheim Investigational Site, Hitachinaka, Ibaraki
1218.78.019 Boehringer Ingelheim Investigational Site, Isesaki, Gunma
1218.78.036 Boehringer Ingelheim Investigational Site, Kashiwara, Osaka
1218.78.026 Boehringer Ingelheim Investigational Site, Kasugai, Aichi
1218.78.038 Boehringer Ingelheim Investigational Site, Kawachinagano, Osaka
1218.78.021 Boehringer Ingelheim Investigational Site, Kitaazumi-gun, Nagano
1218.78.022 Boehringer Ingelheim Investigational Site, Matsumoto, Nagano
1218.78.033 Boehringer Ingelheim Investigational Site, Matsumoto, Nagano
1218.78.012 Boehringer Ingelheim Investigational Site, Meguro-ku, Tokyo
1218.78.041 Boehringer Ingelheim Investigational Site, Meguro-ku, Tokyo
1218.78.034 Boehringer Ingelheim Investigational Site, Morioka, Iwate
1218.78.035 Boehringer Ingelheim Investigational Site, Morioka, Iwate
1218.78.018 Boehringer Ingelheim Investigational Site, Moriya, Ibaraki
1218.78.024 Boehringer Ingelheim Investigational Site, Nagoya, Aichi
1218.78.025 Boehringer Ingelheim Investigational Site, Nagoya, Aichi
1218.78.027 Boehringer Ingelheim Investigational Site, Nagoya, Aichi
1218.78.028 Boehringer Ingelheim Investigational Site, Nagoya, Aichi
1218.78.031 Boehringer Ingelheim Investigational Site, Nagoya, Aichi
1218.78.039 Boehringer Ingelheim Investigational Site, Oita, Oita
1218.78.004 Boehringer Ingelheim Investigational Site, Okinawa, Okinawa
1218.78.016 Boehringer Ingelheim Investigational Site, Sagae, Yamagata
1218.78.001 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido
1218.78.020 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido
1218.78.042 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido
1218.78.005 Boehringer Ingelheim Investigational Site, Shimajiri-gun, Okinawa
1218.78.014 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo
1218.78.002 Boehringer Ingelheim Investigational Site, Shinjyuku-ku. Tokyo
1218.78.011 Boehringer Ingelheim Investigational Site, Shizuoka, Shizuoka
1218.78.003 Boehringer Ingelheim Investigational Site, Suita, Osaka
1218.78.023 Boehringer Ingelheim Investigational Site, Tokorozawa, Saitama
1218.78.029 Boehringer Ingelheim Investigational Site, Tokorozawa, Saitama
1218.78.010 Boehringer Ingelheim Investigational Site, Tsuchiura, Ibaraki
1218.78.015 Boehringer Ingelheim Investigational Site, Yamagata, Yamagata
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Boehringer Ingelheim
INDUSTRY